Phage Therapy to Control Pathogenic Bacteria

Dear Colleagues,

Bacteriophages were discovered in the early 1920s; however, poor understanding of the mechanisms underlying bacterial pathogenesis and the nature of bacteriophage-host interactions, led to a succession of badly designed and executed experiments. This method of antimicrobial treatment was used to treat and prevent bacterial infection diseases both in the former Soviet Union and Eastern Europe, but it was abandoned by the West in the 1940s with the advent of chemical antibiotics. The emergence of pathogenic bacteria resistant to antibiotics, has motivated the scientific community to re-evaluate bacteriophage therapy as a valid option for the treatment of bacterial infections. In recent years, several reports have been published about the successful use of bacteriophages in different fields such as veterinary, agriculture, food safety, aquaculture, and human health. However, this technology is still in development and there are challenges to overcome before bacteriophages can be widely used to control pathogenic bacteria.

This Special Issue of "Phage Therapy to Control Pathogenic Bacteria " will publish the most recent advances in bacteriophage research for bacterial disease control in different areas (veterinary medicine, food industry, agriculture, aquaculture, and human medicine).

Dr. Carla Pereira
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.